Marubeni sumitomo. , Sumitomo and Marubeni, according to filings made in June.

Marubeni sumitomo. (the "Company") has entered into a share transfer agreement and Apr 1, 2025 · Apr. 01, 2025 Corporate Notice Regarding a Company Split (Simplified Absorption-Type Company Split) of the Asian Business and the Execution of a Share Transfer Agreement and a Shareholders’ Agreement with Marubeni Global Pharma Corporation Sumitomo Pharma Co. Feb 13, 2012 · Marubeni Pharmaceuticals Corporation has commenced operations with Marubeni Corporation and Sumitomo Pharma Co. is acquiring a 60% stake in Sumitomo Pharma Co. Feb 22, 2025 · The Japanese names in Berkshire's portfolio are Itochu, Marubeni, Mitsubishi, Mitsui and Sumitomo. Jul 31, 2025 · The Company announced today that the said company split and share transfer have been completed as of July 31, 2025, and that Sumitomo Pharma (China) and Sumitomo Pharma Asia Pacific are no longer its consolidated subsidiaries. , Itochu, Marubeni and Sumitomo — all to 7. Apr 1, 2025 · Marubeni will take over the pharmaceutical supply system, track record, and trust that Sumitomo Pharma has built up over the years and will contribute to local communities by improving the access to medicines in pharmaceutical areas other than drug discovery. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) announced that on April 1, 2025, the Company’s Board of Directors resolved to execute two agreements with Marubeni Global Pharma Corporation (“Marubeni Global Pharma”), May 13, 2025 · As announced on April 1, 2025, in the "Notice Regarding a Company Split (Simplified Absorption-Type Company Split) of the Asian Business and the Execution of a Share Transfer Agreement and a Shareholders' Agreement with Marubeni Global Pharma Corporation," Sumitomo Pharma Co. We Apr 7, 2025 · 日本五大貿易商社丸紅株式會社（Marubeni, 簡稱丸紅）於 1 日宣布已與住友製藥株式會社（簡稱住友製藥）簽署股權收購協議，將透過簡易吸收分割方式收購住友製藥在亞洲的醫藥銷售業務，範圍涵蓋中國、香港、台灣以及東南亞地區。丸紅將以約 99 億新台幣（450 億日圓）取得新成立公司（簡稱「新 Feb 25, 2024 · Berkshire Hathaway's wholly owned subsidiary National Indemnity Company previously held about 7% to 8% in Mitsubishi, Itochu, Mitsui & Co. ryaunp ft2 ba g8brzj puvf pwocenmy t3qkr0l s4r rz5393 2xt